Viewing Study NCT05163834


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-28 @ 4:26 AM
Study NCT ID: NCT05163834
Status: COMPLETED
Last Update Posted: 2022-03-17
First Post: 2021-11-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV
Sponsor: argenx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module